The National Pediatric Cancer Foundation (NPCF) will hold its Annual Research Summit for the country’s leading pediatric cancer research investigators and coordinators on February 14th and 15th of 2019 at the Hilton Airport Hotel Westshore in Tampa.
The nation’s leading pediatric cancer researchers will present groundbreaking information about new research projects and clinical trials aimed at treating and curing pediatric cancer. Researchers from Nationwide, CHLA, Vanderbilt, University of Florida, Moffit Cancer Center, Sylvester Cancer Center, MD Anderson, Primary Children’s, Colorado, Phoenix Children’s, and other leading institutions will be in attendance.
The Sunshine Project, funded exclusively by the National Pediatric Cancer Foundation, is a business model unlike any other in the field of pediatric cancer research. “The Sunshine Project capitalizes on the strengths of researchers and leading hospitals around the country,” said NPCF Chief Executive Officer, David Frazer.
Sunshine Project investigators perform three vital phases of research simultaneously: basic science, translational research, and clinical trials. These major research components not only allow doctors to identify new agents in fighting cancer but also help researchers understand the cancer cells’ response to certain treatments.
Summit presentations will cover current and future phase one trials addressing collaborative efforts to aggressively pursue a measurable change in the way pediatric cancer is treated. Our studies focus on less toxic, more targeted treatments for children.
“This Summit helps get everyone on the same page, clarifies our goals, builds momentum and sets the agenda for the next year,” said Sunshine Project Lead Investigator Damon Reed, M.D., who works at Moffitt Cancer Center and John Hopkins All Children’s Hospital in Tampa Bay. “It’s also a great opportunity for the researchers to network, learn, collaborate and take things back to their institutions that they may not have thought of before.”